• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用电化学检测法对红霉素及其酯类进行高效液相色谱分析。

High-performance liquid chromatographic assay of erythromycin and its esters using electrochemical detection.

作者信息

Croteau D, Vallée F, Bergeron M G, LeBel M

机构信息

Université Laval, Centre Hospitalier, de l'Université Laval, Quebec, Canada.

出版信息

J Chromatogr. 1987 Aug 7;419:205-12. doi: 10.1016/0378-4347(87)80278-5.

DOI:10.1016/0378-4347(87)80278-5
PMID:3499443
Abstract

A high-performance liquid chromatographic analysis of erythromycin and its esters in plasma, urine and saliva is presented. A diethyl ether extract of sample was chromatographed on a reversed-phase column and components of the column effluent were monitored by electrochemical detection at +0.9 V (vs. Ag/AgCl). The method sensitivity limit was 10 ng with inter-day coefficients of variation from 3.2 to 10.3%. In order to assess precisely the relative concentrations of erythromycin esters (ethylsuccinate or estolate) and their active by-product erythromycin base, it is necessary to adopt measures preventing their continuous hydrolysis in biological fluids and during sample preparation.

摘要

本文介绍了血浆、尿液和唾液中红霉素及其酯类的高效液相色谱分析方法。样品的乙醚提取物在反相柱上进行色谱分离,柱流出物的成分通过在+0.9 V(相对于Ag/AgCl)下的电化学检测进行监测。该方法的灵敏度极限为10 ng,日间变异系数为3.2%至10.3%。为了精确评估红霉素酯(乙基琥珀酸酯或依托红霉素)及其活性副产物红霉素碱的相对浓度,有必要采取措施防止它们在生物流体和样品制备过程中持续水解。

相似文献

1
High-performance liquid chromatographic assay of erythromycin and its esters using electrochemical detection.采用电化学检测法对红霉素及其酯类进行高效液相色谱分析。
J Chromatogr. 1987 Aug 7;419:205-12. doi: 10.1016/0378-4347(87)80278-5.
2
Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.通过高压液相色谱法测定依托红霉素相对于琥乙红霉素的药代动力学优势。
Antimicrob Agents Chemother. 1988 Apr;32(4):561-5. doi: 10.1128/AAC.32.4.561.
3
Analysis of erythromycin in biological fluids by high-performance liquid chromatography with electrochemical detection.采用高效液相色谱-电化学检测法分析生物流体中的红霉素。
J Chromatogr. 1983 Nov 11;278(1):91-100. doi: 10.1016/s0378-4347(00)84759-3.
4
High-performance liquid chromatography of erythromycin propionyl ester and erythromycin base in biological fluids.生物体液中丙酰基红霉素和红霉素碱的高效液相色谱法
J Chromatogr. 1988 May 13;427(1):93-101. doi: 10.1016/0378-4347(88)80107-5.
5
Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.琥乙红霉素和依托红霉素在4个月以下婴儿中的药代动力学。
Antimicrob Agents Chemother. 1981 May;19(5):736-9. doi: 10.1128/AAC.19.5.736.
6
Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.对健康志愿者给予无味红霉素和琥乙红霉素后血浆杀菌活性的研究。
Antimicrob Agents Chemother. 1988 Aug;32(8):1227-30. doi: 10.1128/AAC.32.8.1227.
7
A simple thin-layer chromatographic identification procedure for erythromycin base, stearate, estolate and ethylsuccinate.
J Chromatogr. 1977 Mar 11;133(1):239-44. doi: 10.1016/s0021-9673(00)89232-8.
8
Sensitive high-performance liquid chromatographic determination of EM523, a new erythromycin derivative, in human plasma and urine with ultraviolet detection using column switching.采用柱切换紫外检测的高效液相色谱法灵敏测定人血浆和尿液中新型红霉素衍生物EM523。
J Chromatogr. 1993 Jun 23;616(1):144-50. doi: 10.1016/0378-4347(93)80481-i.
9
Micro-method for the determination of roxithromycin in human plasma and urine by high-performance liquid chromatography using electrochemical detection.高效液相色谱-电化学检测法测定人血浆和尿液中罗红霉素的微量方法。
J Chromatogr. 1989 May 5;490(1):115-23. doi: 10.1016/s0378-4347(00)82766-8.
10
Determination of erythromycin base and 2'-acetylerythromycin in human plasma using high-performance liquid chromatography with electrochemical detection.使用高效液相色谱-电化学检测法测定人血浆中红霉素碱和2'-乙酰红霉素。
J Chromatogr. 1990 Apr 6;526(2):475-86. doi: 10.1016/s0378-4347(00)82529-3.

引用本文的文献

1
Clinical evidences on the antiviral properties of macrolide antibiotics in the COVID-19 era and beyond.大环内酯类抗生素在新冠疫情时代及以后的抗病毒特性的临床证据。
Antivir Chem Chemother. 2020 Jan-Dec;28:2040206620961712. doi: 10.1177/2040206620961712.
2
Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.通过高压液相色谱法测定依托红霉素相对于琥乙红霉素的药代动力学优势。
Antimicrob Agents Chemother. 1988 Apr;32(4):561-5. doi: 10.1128/AAC.32.4.561.
3
Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.
对健康志愿者给予无味红霉素和琥乙红霉素后血浆杀菌活性的研究。
Antimicrob Agents Chemother. 1988 Aug;32(8):1227-30. doi: 10.1128/AAC.32.8.1227.
4
Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.阿奇霉素:抗菌活性、药代动力学特性及临床疗效综述
Drugs. 1992 Nov;44(5):750-99. doi: 10.2165/00003495-199244050-00007.